Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Dow
Citi
Moodys
Cantor Fitzgerald
Deloitte
Fuji
Mallinckrodt

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040183

« Back to Dashboard

NDA 040183 describes METHYLPREDNISOLONE, which is a drug marketed by Elkins Sinn, Organon Usa Inc, Duramed Pharms Barr, Heather, Jubilant Cadista, Par Pharm, Sandoz, Vintage Pharms, Watson Labs, Akorn, Sandoz Inc, Teva Pharms Usa, Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma Farmaceutica, Intl Medication, Sagent Pharms, and Teva Parenteral, and is included in fifty-five NDAs. It is available from twenty-three suppliers. Additional details are available on the METHYLPREDNISOLONE profile page.

The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 040183
Pharmacology for NDA: 040183
Medical Subject Heading (MeSH) Categories for 040183
Suppliers and Packaging for NDA: 040183
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 040183 ANDA Par Pharmaceutical 0603-4593 N 0603-4593-15
METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 040183 ANDA Par Pharmaceutical 0603-4593 N 0603-4593-21

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Dec 22, 1998TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
AstraZeneca
Julphar
Medtronic
Citi
Federal Trade Commission
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.